12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Deals

Galapagos, J&J deal

Galapagos received a €4 million ($5.3 million) milestone payment from Johnson & Johnson's Janssen Pharmaceutica N.V. subsidiary under a 2007 deal to develop and commercialize...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >